/Companies

Vasculox

Saint Louis, US · Delaware corporation · 2 known investors

Find your way into Vasculox

Sign up to see every warm intro you have to Vasculox

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vasculox team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

KL
Kalthleen L. BeckmannExecutive
RW
Robert W. KarrExecutive
PM
Pamela ManningExecutive
WF
William FrazierNamed on SEC filing

Board

JMJohn McKearn
John McKearnBoard directorSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
CB
Charles BoltenBoard director
BS
Bobby Sandage, Jr.Board director
DB
Dan BroderickBoard director

Investors · 2

Funding

SEC filings, press & company announcements

$34.4M disclosed across 2 of 3 rounds · 2014–2016

▶$33.2MraisedAug 2016 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John McKearnDirector
  • John DonovanExecutive Officer, Director
  • James StutzExecutive Officer
  • Carole L. NuechterleinDirector
  • Pamela T. ManningExecutive Officer
  • Robert W. KarrExecutive Officer
  • Jill CarrollDirector
  • Peter MoldtDirector
Offering amount
$86.3M
Amount sold
$33.2M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedFeb 2015 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kalthleen L. BeckmannExecutive Officer
  • Charles BoltenDirector
  • Bobby Sandage, Jr.Director
  • William FrazierDirector
  • Robert W. KarrExecutive Officer, Director
  • Pamela ManningExecutive Officer
  • John McKearnDirector
  • Dan BroderickDirector
Offering amount
$2.8M
Amount sold
$1.3M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Vasculox's investors?
Vasculox's investors include RiverVest Venture Partners, Roche Venture Fund.
How much funding has Vasculox raised?
Vasculox has disclosed $34.4M raised across 2 of its 3 known rounds.
Where is Vasculox headquartered?
Vasculox is headquartered in Saint Louis, US.